BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32439865)

  • 1. Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers.
    Sfakianos JP; Daza J; Hu Y; Anastos H; Bryant G; Bareja R; Badani KK; Galsky MD; Elemento O; Faltas BM; Mulholland DJ
    Nat Commun; 2020 May; 11(1):2540. PubMed ID: 32439865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity.
    Wang ZA; Mitrofanova A; Bergren SK; Abate-Shen C; Cardiff RD; Califano A; Shen MM
    Nat Cell Biol; 2013 Mar; 15(3):274-83. PubMed ID: 23434823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder.
    Masuda N; Murakami K; Kita Y; Hamada A; Kamada M; Teramoto Y; Sakatani T; Matsumoto K; Sano T; Saito R; Okuno Y; Ogawa O; Kobayashi T
    Am J Pathol; 2020 Aug; 190(8):1752-1762. PubMed ID: 32339497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraclonal Plasticity in Mammary Tumors Revealed through Large-Scale Single-Cell Resolution 3D Imaging.
    Rios AC; Capaldo BD; Vaillant F; Pal B; van Ineveld R; Dawson CA; Chen Y; Nolan E; Fu NY; ; Jackling FC; Devi S; Clouston D; Whitehead L; Smyth GK; Mueller SN; Lindeman GJ; Visvader JE
    Cancer Cell; 2019 Apr; 35(4):618-632.e6. PubMed ID: 30930118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Luminal and Basal Phenotypes in Bladder Cancer.
    Guo CC; Bondaruk J; Yao H; Wang Z; Zhang L; Lee S; Lee JG; Cogdell D; Zhang M; Yang G; Dadhania V; Choi W; Wei P; Gao J; Theodorescu D; Logothetis C; Dinney C; Kimmel M; Weinstein JN; McConkey DJ; Czerniak B
    Sci Rep; 2020 Jun; 10(1):9743. PubMed ID: 32546765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N
    Jin H; Ying X; Que B; Wang X; Chao Y; Zhang H; Yuan Z; Qi D; Lin S; Min W; Yang M; Ji W
    EBioMedicine; 2019 Sep; 47():195-207. PubMed ID: 31409574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification.
    Sjödahl G; Eriksson P; Liedberg F; Höglund M
    J Pathol; 2017 May; 242(1):113-125. PubMed ID: 28195647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiles of Immune Infiltration in Bladder Cancer and its Clinical Significance: an Integrative Genomic Analysis.
    Wu Z; Zhu K; Liu Q; Liu Y; Chen L; Cui J; Guo H; Zhou N; Zhu Y; Li Y; Shi B
    Int J Med Sci; 2020; 17(6):762-772. PubMed ID: 32218698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Lineage-specific Transcriptional Factor-defined Molecular Subtypes in Small Cell Bladder Cancer.
    Feng M; Matoso A; Epstein G; Fong M; Park YH; Gabrielson A; Patel S; Czerniak B; Compérat E; Hoffman-Censits J; Kates M; Kim S; McConkey D; Choi W
    Eur Urol; 2024 Jun; 85(6):523-526. PubMed ID: 37380560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression.
    Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG
    Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of
    Ecke TH; Kiani A; Schlomm T; Friedersdorff F; Rabien A; Jung K; Kilic E; Boström P; Tervahartiala M; Taimen P; Gleichenhagen J; Johnen G; Brüning T; Koch S; Roggisch J; Wirtz RM
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer.
    Ochoa AE; Choi W; Su X; Siefker-Radtke A; Czerniak B; Dinney C; McConkey DJ
    Oncotarget; 2016 Dec; 7(49):80164-80174. PubMed ID: 27845906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer.
    Lai H; Cheng X; Liu Q; Luo W; Liu M; Zhang M; Miao J; Ji Z; Lin GN; Song W; Zhang L; Bo J; Yang G; Wang J; Gao WQ
    Int J Cancer; 2021 Dec; 149(12):2099-2115. PubMed ID: 34480339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathology and biomarkers of bladder cancer.
    Czerniak B
    Cancer Biomark; 2010; 9(1-6):159-76. PubMed ID: 22112475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of expression patterns of keratin 6, 7, 16, 17, and 19 within multiple independent isolates of As(+3)- and Cd (+2)-induced bladder cancer : keratin 6, 7, 16, 17, and 19 in bladder cancer.
    Somji S; Cao L; Mehus A; Zhou XD; Sens MA; Dunlevy JR; Garrett SH; Zheng Y; Larson JL; Sens DA
    Cell Biol Toxicol; 2011 Dec; 27(6):381-96. PubMed ID: 21927821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell analyses of transcriptional heterogeneity in squamous cell carcinoma of urinary bladder.
    Zhang X; Zhang M; Hou Y; Xu L; Li W; Zou Z; Liu C; Xu A; Wu S
    Oncotarget; 2016 Oct; 7(40):66069-66076. PubMed ID: 27602771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer.
    Lee SR; Roh YG; Kim SK; Lee JS; Seol SY; Lee HH; Kim WT; Kim WJ; Heo J; Cha HJ; Kang TH; Chung JW; Chu IS; Leem SH
    Clin Cancer Res; 2015 Dec; 21(23):5391-403. PubMed ID: 26268246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells.
    Jia AY; Castillo-Martin M; Domingo-Domenech J; Bonal DM; Sánchez-Carbayo M; Silva JM; Cordon-Cardo C
    Am J Pathol; 2013 Apr; 182(4):1171-9. PubMed ID: 23410519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological determinants of bladder cancer gene expression subtypes.
    Aine M; Eriksson P; Liedberg F; Sjödahl G; Höglund M
    Sci Rep; 2015 Jun; 5():10957. PubMed ID: 26051783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.